During the first 12 to 16 weeks of treatment, many people experience a small, transient decline in estimated glomerular filtration rate (eGFR), which corresponds to a slight increase in serum creatinine
For patients with prediabetes or insulin resistance driving weight gain and metabolic dysfunction, semaglutide addresses the glycemic component while producing weight loss that further improves insulin sensitivity a compounding metabolic benefit
As with all high-performance actives, results depend on consistent use and should always be paired with daily SPF protection
Sjstrm, L., Rissanen, A., Andersen, T., et al
Lancet 390(10103):16641675
Not sure what I get in the injections Great company and product